Literature DB >> 2953809

Inhibition of IL 2-driven proliferation of murine T lymphocyte clones by supraoptimal levels of immobilized anti-T cell receptor monoclonal antibody.

G J Nau, R L Moldwin, D W Lancki, D K Kim, F W Fitch.   

Abstract

Both cloned murine helper T lymphocytes (HTL) and cytolytic T lymphocytes (CTL) proliferated and secreted lymphokines when stimulated with immobilized anti-T cell receptor monoclonal antibody (anti-TCR mAb). However, although proliferation of CTL increased and reached plateau levels as concentrations of anti-TCR mAb were increased, the proliferation of HTL decreased with high concentrations of anti-TCR mAb. A reduction of IL 2-dependent proliferation by CTL was observed when IL 2 was added to cultures of CTL in the presence of high concentrations of anti-TCR mAb, whereas IL 2-independent proliferation appeared to be unaffected by these concentrations of anti-TCR mAb. Inhibition of IL 2-driven proliferation caused by high concentrations of immobilized anti-TCR mAb did not seem to be mediated by soluble factors. Cells continued to express cell surface receptors for IL 2 and transferrin after treatment with immobilized anti-TCR mAb. Inhibition of IL 2-driven proliferation by high concentrations of immobilized anti-TCR mAb may represent a mechanism for regulating the proliferation of T lymphocytes. This inhibitory mechanism is initiated by stimulation of the T cell receptor, in this case by immobilized anti-TCR mAb, and is independent of other cells and factors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953809

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction.

Authors:  D Strickland; U R Kees; P G Holt
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  CD8+ T-cell clones deficient in the expression of the CD45 protein tyrosine phosphatase have impaired responses to T-cell receptor stimuli.

Authors:  C T Weaver; J T Pingel; J O Nelson; M L Thomas
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

3.  Receptor-stimulated death pathway is opened by antigen in mature T cells.

Authors:  J H Russell; C L White; D Y Loh; P Meleedy-Rey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

4.  Early IL-2/sIL-2R surge following surgery leads to temporary immune refractoriness.

Authors:  N Lahat; R Shtiller; A Y Zlotnick; G Merin
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

5.  CD4+ T-cell dynamics and host predisposition to infection.

Authors:  A N Schweitzer
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

6.  "Anergy" of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype.

Authors:  T F Gajewski; D W Lancki; R Stack; F W Fitch
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

7.  Requirements for activation of CD8+ murine T cells. I. Development of cytolytic activity.

Authors:  D C Cronin; D W Lancki; F W Fitch
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

8.  Reduced lysis by CD8+ cytotoxic T cells in mixed lymphocyte reactions induced via CD4+ T cells exposed to chemically modified antigen presenting cells.

Authors:  L Corlett; D H Davies
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

9.  Immunosuppression follows systemic T lymphocyte activation in the burn patient.

Authors:  J A Teodorczyk-Injeyan; B G Sparkes; G B Mills; W J Peters
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

Review 10.  The role of activation-induced cell death in the differentiation of T-helper-cell subsets.

Authors:  Arthur I Roberts; Satish Devadas; Xiaoren Zhang; Liying Zhang; Achsah Keegan; Kristy Greeneltch; Jennifer Solomon; Lixin Wei; Jyoti Das; Erwei Sun; Catherine Liu; Zengrong Yuan; Jian-Nian Zhou; Yufang Shi
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.